Fair Value Calculator Fair Value Calculator
EN DE

Extreme Biodiesel, Inc (XTRM) Fair Value & Analysis

Real Estate · US · Market cap $246K

EB Extreme Biodiesel, Inc logo Extreme Biodiesel, Inc XTRM · US
Price$0.0001
Fair Value$0.0001
Upside+0.0%
Quality35/100
Watch Extreme Biodiesel, Inc for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range $0.0001 – $0.0001

Fair value as of: Jun 26, 2026

From 23 valuation models · updated 7 days ago

Price vs Fair Value (12 months)

$0.0001 $0.0001 Fair Value $0.0001 Jul 2025 Jul 2026

12‑month range $0.0001 – $0.0001 · the $0.0001 price screens below the $0.0001 fair value. As of Jun 26, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Extreme Biodiesel, Inc (XTRM) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 35/100 (below-average quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Trailing-twelve-month revenue stands at $73.6K. Revenue declined 49.1% year over year. Net debt stands at $6.5M. Fundamentals as of Jun 26, 2026

Key figures & financial health

Revenue (TTM) $73.6K
Revenue growth (YoY) -49.1%
Return on equity -150%
Free cash flow $1.4M FY2022
Operating margin -82.0%
Net debt $6.5M FY2022

Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.

About the company

Extreme Biodiesel, Inc. engages in the development, marketing, and commercialization of bio-diesel fuel, home bio-diesel processors, and related products. The company is based in Corona, California.

Revenue & earnings trend

FY2013 – FY2022 · reported fiscal years

Extreme Biodiesel, Inc reported revenue of $8.4M in FY2022 versus $77 in FY2013, a compound +262.8%/yr. Reported net income was $14.6K in FY2022.

Revenue +262.8%/yr
FY13 $77
FY14 $40
FY20 $12.3M
FY21 $13.5M
FY22 $8.4M
Net income
FY14 −$164
FY18 −$2.1K
FY20 $299K
FY21 $996K
FY22 $14.6K

Is XTRM fairly valued? → Check now

Similar stocks

6 more Real Estate - Development stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).

Stock Price Fair Value vs Fair Value
Vinhomes Joint Stock Company VHM 146,800 VND 148,549 VND +1%
DLF Limited DLF ₹627.60 ₹215.17 -66%
PT Pantai Indah Kapuk Dua Tbk, PANI 6,650 IDR 1,330 IDR -80%
Lodha Developers Limited LODHA ₹862.00 ₹721.45 -16%
Oberoi Realty Limited OBEROIRLTY ₹1,633 ₹1,368 -16%
Godrej Properties Limited GODREJPROP ₹1,642 ₹788.35 -52%

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Extreme Biodiesel, Inc (XTRM) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001 — about +0% (undervalued). Model-based estimate, not financial advice.
What is the fair value of XTRM?
Our model-based fair value for Extreme Biodiesel, Inc is $0.0001 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0001.
What is the quality score of XTRM?
Extreme Biodiesel, Inc has a Quality Score of 35/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Extreme Biodiesel, Inc (XTRM)?
Extreme Biodiesel, Inc reported trailing-twelve-month revenue of about $73.6K (latest available figure, as of Jun 26, 2026).
What is the net profit margin of XTRM?
The net profit margin of Extreme Biodiesel, Inc is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.